Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells

BACKGROUND: The development of immunotherapy has led to significant progress in the treatment of metastatic cancer, including the development of genetic engineering technologies that redirect lymphocytes to recognize and target a wide variety of tumor antigens. Chimeric antigen receptors (CARs) are...

Descripción completa

Detalles Bibliográficos
Autores principales: Beard, Rachel E, Zheng, Zhili, Lagisetty, Kiran H, Burns, William R, Tran, Eric, Hewitt, Stephen M, Abate-Daga, Daniel, Rosati, Shannon F, Fine, Howard A, Ferrone, Soldano, Rosenberg, Steven A, Morgan, Richard A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155770/
https://www.ncbi.nlm.nih.gov/pubmed/25197555
http://dx.doi.org/10.1186/2051-1426-2-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155770/
https://www.ncbi.nlm.nih.gov/pubmed/25197555
http://dx.doi.org/10.1186/2051-1426-2-25

Ejemplares similares